183 related articles for article (PubMed ID: 7562327)
1. In vitro activity of tetracyclines, macrolides, quinolones, clindamycin and metronidazole against periodontopathic bacteria.
Miyake Y; Tsuruda K; Okuda K; Widowati ; Iwamoto Y; Suginaka H
J Periodontal Res; 1995 Jul; 30(4):290-3. PubMed ID: 7562327
[TBL] [Abstract][Full Text] [Related]
2. [Antibacterial activity of new-quinolone and macrolide antibiotics against oral bacteria].
Eguchi T; Shimizu Y; Furuhata K; Fukuyama M
Kansenshogaku Zasshi; 2002 Nov; 76(11):939-45. PubMed ID: 12508477
[TBL] [Abstract][Full Text] [Related]
3. Development of resistance to metronidazole and minocycline in vitro.
Larsen T; Fiehn NE
J Clin Periodontol; 1997 Apr; 24(4):254-9. PubMed ID: 9144048
[TBL] [Abstract][Full Text] [Related]
4. High resistance against clindamycin, metronidazole and amoxicillin in Porphyromonas gingivalis and Aggregatibacter actinomycetemcomitans isolates of periodontal disease.
Ardila CM; López MA; Guzmán IC
Med Oral Patol Oral Cir Bucal; 2010 Nov; 15(6):e947-51. PubMed ID: 20383102
[TBL] [Abstract][Full Text] [Related]
5. Antimicrobial susceptibilities of Porphyromonas gingivalis, Prevotella intermedia, and Prevotella nigrescens spp. isolated in Spain.
Andrés MT; Chung WO; Roberts MC; Fierro JF
Antimicrob Agents Chemother; 1998 Nov; 42(11):3022-3. PubMed ID: 9797247
[TBL] [Abstract][Full Text] [Related]
6. Quantitative real-time PCR using TaqMan and SYBR Green for Actinobacillus actinomycetemcomitans, Porphyromonas gingivalis, Prevotella intermedia, tetQ gene and total bacteria.
Maeda H; Fujimoto C; Haruki Y; Maeda T; Kokeguchi S; Petelin M; Arai H; Tanimoto I; Nishimura F; Takashiba S
FEMS Immunol Med Microbiol; 2003 Oct; 39(1):81-6. PubMed ID: 14557000
[TBL] [Abstract][Full Text] [Related]
7. Distribution of biotypes and antimicrobial susceptibility of Actinobacillus actinomycetemcomitans.
Avila-Campos MJ; Carvalho MA; Zelante F
Oral Microbiol Immunol; 1995 Dec; 10(6):382-4. PubMed ID: 8602348
[TBL] [Abstract][Full Text] [Related]
8. Acquisition and loss of Porphyromonas gingivalis, Actinobacillus actinomycetemcomitans and Prevotella intermedia over a 5-year period: effect of a triclosan/copolymer dentifrice.
Cullinan MP; Hamlet SM; Westerman B; Palmer JE; Faddy MJ; Seymour GJ
J Clin Periodontol; 2003 Jun; 30(6):532-41. PubMed ID: 12795792
[TBL] [Abstract][Full Text] [Related]
9. Inhibitory effects of lactoferrin on growth and biofilm formation of Porphyromonas gingivalis and Prevotella intermedia.
Wakabayashi H; Yamauchi K; Kobayashi T; Yaeshima T; Iwatsuki K; Yoshie H
Antimicrob Agents Chemother; 2009 Aug; 53(8):3308-16. PubMed ID: 19451301
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory activity of green tea (Camellia sinensis) extract on some clinically isolated cariogenic and periodontopathic bacteria.
Araghizadeh A; Kohanteb J; Fani MM
Med Princ Pract; 2013; 22(4):368-72. PubMed ID: 23485656
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of antibiotics against periodontopathogenic bacteria within epithelial cells: an in vitro study.
Eick S; Pfister W
J Periodontol; 2004 Oct; 75(10):1327-34. PubMed ID: 15562909
[TBL] [Abstract][Full Text] [Related]
12. E-test: a new technique for antimicrobial susceptibility testing for periodontal microorganisms.
Nachnani S; Scuteri A; Newman MG; Avanessian AB; Lomeli SL
J Periodontol; 1992 Jul; 63(7):576-83. PubMed ID: 1324301
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial activity of tannin components from Vaccinium vitis-idaea L.
Ho KY; Tsai CC; Huang JS; Chen CP; Lin TC; Lin CC
J Pharm Pharmacol; 2001 Feb; 53(2):187-91. PubMed ID: 11273014
[TBL] [Abstract][Full Text] [Related]
14. In vitro antimicrobial susceptibility of oral strains of Actinobacillus actinomycetemcomitans to seven antibiotics.
Müller HP; Holderrieth S; Burkhardt U; Höffler U
J Clin Periodontol; 2002 Aug; 29(8):736-42. PubMed ID: 12390570
[TBL] [Abstract][Full Text] [Related]
15. Metronidazole susceptibility testing of anaerobic bacteria associated with periodontal disease.
Poulet PP; Duffaut D; Lodter JP
J Clin Periodontol; 1999 Apr; 26(4):261-3. PubMed ID: 10223399
[TBL] [Abstract][Full Text] [Related]
16. Selective inhibition of Porphyromonas gingivalis growth by a factor Xa inhibitor, DX-9065a.
Matsushita K; Imamura T; Tancharoen S; Tatsuyama S; Tomikawa M; Travis J; Potempa J; Torii M; Maruyama I
J Periodontal Res; 2006 Jun; 41(3):171-6. PubMed ID: 16677284
[TBL] [Abstract][Full Text] [Related]
17. Comparative potency of gemifloxacin, new quinolones, macrolides, tetracycline and clindamycin against Mycoplasma spp.
Duffy LB; Crabb D; Searcey K; Kempf MC
J Antimicrob Chemother; 2000 Apr; 45 Suppl 1():29-33. PubMed ID: 10824029
[TBL] [Abstract][Full Text] [Related]
18. Antimicrobial susceptibility of periodontopathogenic bacteria.
Kulik EM; Lenkeit K; Chenaux S; Meyer J
J Antimicrob Chemother; 2008 May; 61(5):1087-91. PubMed ID: 18326855
[TBL] [Abstract][Full Text] [Related]
19. In-vitro susceptibilities of Mycoplasma pneumoniae, Mycoplasma hominis and Ureaplasma urealyticum to clinafloxacin, PD 131628, ciprofloxacin and comparator drugs.
Cohen MA; Huband MD
J Antimicrob Chemother; 1997 Aug; 40(2):308-9. PubMed ID: 9302005
[No Abstract] [Full Text] [Related]
20. Antibacterial activity of hinokitiol against both antibiotic-resistant and -susceptible pathogenic bacteria that predominate in the oral cavity and upper airways.
Domon H; Hiyoshi T; Maekawa T; Yonezawa D; Tamura H; Kawabata S; Yanagihara K; Kimura O; Kunitomo E; Terao Y
Microbiol Immunol; 2019 Jun; 63(6):213-222. PubMed ID: 31106894
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
